用内镜超声波引导的组织采集用于诊断肝脏恶性淋巴瘤
Yuichi Takano1, Naoki Tamai1, Jun Noda1
1Division of Gastroenterology, Department of Internal Medicine Showa Medical University Fujigaoka Hospital Yokohama Kanagawa Japan.
Clinical case reports
|January 23, 2026
概括
用内镜超声波引导的组织采集 (EUS-TA) 在肝脏群体中安全诊断出高等级T细胞淋巴瘤. EUS-TA为肝脏恶性淋巴瘤提供了皮肤透析活检的有效替代方案.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 诊断成像 诊断成像 诊断成像
背景情况:
- 肝脏质量可以呈现出诸如右上象限疼痛和发烧等症状.
- 肝脏恶性淋巴瘤的诊断通常需要组织活检.
研究的目的:
- 评估内镜超声导向组织采集 (EUS-TA) 对于诊断肝脏恶性淋巴瘤的实用性.
- 评估EUS-TA在患有未诊断肝脏质量的患者的安全性和有效性.
主要方法:
- 一名62岁的男性患者出现了右上象限疼痛和发烧.
- 诊断成像显示了多个肝脏质量.
- 用22-gauge细针活检进行了内镜超声导向组织采集 (EUS-TA).
主要成果:
- EUS-TA成功地从肝脏群体中获得了组织样本.
- 组织病理学分析证实了高度T细胞淋巴瘤的诊断.
- 该程序在没有任何不良事件的情况下完成.
结论:
- 透视超声导向组织采集 (EUS-TA) 是诊断肝脏恶性淋巴瘤的安全有效方法.
- EUS-TA为肝脏病变的传统皮肤穿活检提供了一个可行的替代方案.
- 这一案例凸显了EUS-TA在复杂肝病理中的诊断潜力.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
626
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
626
Diagnosing Acidosis and Alkalosis
1.1K
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Light Acquisition
9.4K
In order to produce glucose, plants need to capture sufficient light energy. Many modern plants have evolved leaves specialized for light acquisition. Leaves can be only millimeters in width or tens of meters wide, depending on the environment. Due to competition for sunlight, evolution has driven the evolution of increasingly larger leaves and taller plants, to avoid shading by their neighbors with contaminant elaboration of root architecture and mechanisms to transport water and nutrients.
9.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219


